Michael Tepedino

Once-Daily Netarsudil Versus Twice-Daily Timolol in Patients With Elevated Intraocular Pressure: The Randomized Phase 3 ROCKET-4 Study

Albert S Khouri, Janet B. Serle, Jason Bacharach et al. · American Journal of Ophthalmology · 2019 · 105 citations

Pharmacy, Ophthalmology, Pharmacotherapy +17

24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients

E. Randy Craven, Thomas R. Walters, William C. Christie et al. · Drugs · 2019 · 100 citations · Full text

Pharmacy, Ophthalmology, Pharmacotherapy +17

Phase III efficacy and safety study of besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis

Michael Tepedino, Warren Heller, Dale W. Usner et al. · Current Medical Research and Opinion · 2009 · 79 citations

Medicine, Ophthalmology, Pharmacotherapy +17

Determinants of Outcomes of Adenoviral Keratoconjunctivitis

Cecilia S. Lee, Aaron Lee, Lakshmi Akileswaran et al. · Ophthalmology · 2018 · 60 citations · Full text

Medicine, Infectious Diseases, Ophthalmology +10

A randomized, investigator-masked clinical trial comparing the efficacy and safety of gatifloxacin 0.3% administered BID versus QID for the treatment of acute bacterial conjunctivitis

Richard W. Yee, Michael Tepedino, Harold G. Jensen et al. · Current Medical Research and Opinion · 2005 · 30 citations

Medicine, Ophthalmology, Pharmacotherapy +16